Pharmaceutical Executive: January 2023

What the c-suite should consider in today’s marketplace.

The parameters governing pharma promotional speech in digital and social media have struggled to keep pace with the rapidly evolving healthcare communications landscape. How can FDA play catch-up in advancing an agenda more reflective of industry and patient needs?

As they are forced to do more with less, pharma commercial leaders should rethink their incentive programs to ensure their sales teams remain strong drivers of growth.

As new forms of cell and gene therapies continue to be developed, life sciences companies and payers need to find alternative ways to pay for these expensive treatments. Value-based contracts, though slow to gain traction so far, may provide the solution these groups are looking for.

Pharma companies are teaming with academic institutions earlier in the R&D process.

Interpreting what the Inflation Reduction Act could mean for biopharma.

How technology will play a big role in advancing pharma approaches in patient support.

As new channels enter healthcare conversation mix, engagement strategies are changing.

An evolving job market has forced life sciences companies to respond.

The steps companies can take now to better protect themselves and their data.

Exploring the most relevant topics affecting the biopharma industry as the new year gets underway—ranging from trends ripe with risk and opportunity to those driving more definitive growth opportunities in patient care.

Natalie Bickford, chief people officer at Sanofi, reveals how she approaches the employee experience, which ultimately influences employee retention, and discusses the importance of a corporate DE&I strategy in those efforts.

What a changing economy and related trends could mean for 2023.

Supporting health plan clinical preparation and financial modeling.

An ecosystem perspective is the first step.

Member states air concerns over excess supplies of COVID vaccines.

2023 is poised to deliver a new set of challenges.

Pharm Exec introduces new managing editor.

Click the title above for a link to open the Pharmaceutical Executive January 2023 issue in an interactive PDF format.